Table 3 Spatial and temporal gait parameters. Results are presented adjusted for age and BMI
Parameter | Least-squares mean | Diff. | 95 % CI | p | ||
|---|---|---|---|---|---|---|
Lower | Upper | |||||
Step Length (cm) | Normouricemic control | 0.61 | ||||
Gout | 0.57 | 0.03 | −0.02 | 0.08 | 0.168 | |
Asymptomatic hyperuricemia | 0.61 | 0.00 | −0.05 | 0.05 | 0.985 | |
Stride Length (cm) | Normouricemic control | 1.21 | ||||
Gout | 1.14 | 0.07 | −0.04 | 0.17 | 0.200 | |
Asymptomatic hyperuricemia | 1.20 | 0.02 | −0.08 | 0.11 | 0.763 | |
Support Base (cm) | Normouricemic control | 0.08 | ||||
Gout | 0.10 | −0.02 | −0.03 | 0.00 | 0.102 | |
Asymptomatic hyperuricemia | 0.11 | −0.03 | −0.05 | −0.01 | 0.002 | |
Step Time (s) | Normouricemic control | 0.60 | ||||
Gout | 0.64 | −0.04 | −0.07 | −0.01 | 0.022 | |
Asymptomatic hyperuricemia | 0.57 | 0.03 | 0.00 | 0.06 | 0.081 | |
Swing Time (s) | Normouricemic control | 0.46 | ||||
Gout | 0.47 | −0.02 | −0.04 | 0.00 | 0.104 | |
Asymptomatic hyperuricemia | 0.43 | 0.03 | 0.01 | 0.05 | 0.019 | |
Stance Time (s) | Normouricemic control | 0.74 | ||||
Gout | 0.80 | −0.06 | −0.10 | −0.01 | 0.022 | |
Asymptomatic hyperuricemia | 0.72 | 0.03 | −0.02 | 0.07 | 0.266 | |
Single Support Time (s) | Normouricemic control | 0.46 | ||||
Gout | 0.48 | −0.02 | −0.04 | 0.00 | 0.092 | |
Asymptomatic hyperuricemia | 0.43 | 0.03 | 0.00 | 0.05 | 0.020 | |
Double Support Time (s) | Normouricemic control | 0.16 | ||||
Gout | 0.16 | 0.00 | −0.04 | 0.04 | 0.857 | |
Asymptomatic hyperuricemia | 0.26 | −0.10 | −0.14 | −0.06 | <0.001 | |
Velocity (m/s) | Normouricemic control | 1.03 | ||||
Gout | 0.91 | 0.11 | 0.00 | 0.23 | 0.050 | |
Asymptomatic hyperuricemia | 1.07 | −0.05 | −0.15 | 0.06 | 0.379 | |
Cadence (steps/min) | Normouricemic control | 100.9 | ||||
Gout | 95.5 | 5.4 | −0.7 | 11.5 | 0.080 | |
Asymptomatic hyperuricemia | 107.3 | −6.5 | −12.2 | −0.7 | 0.028 | |